Byrna Technologies Inc. has 11 Schedule 13D or 13G filings on record since 2025-08-06. 2 holders' latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Bryan S. Ganz | 9.6% | 2,296,635 | SCHEDULE 13D/A, 2026-09-08 | 2026-09-03 |
| Fmr LLC | 7.2% | 1,627,566 | SCHEDULE 13G/A, 2026-08-07 | 2026-07-31 |
| BlackRock, Inc. | 1.7% | 383,826 | SCHEDULE 13G/A, 2026-07-27 | 2026-06-30 |
| Millennium Management LLC | 1.4% | 325,550 | SCHEDULE 13G/A, 2026-07-10 | 2026-06-30 |
| Capital Research Global Investors | 0% | 0 | SCHEDULE 13G/A, 2026-05-14 | 2026-03-31 |
Purpose of Transaction (Item 4)
Bryan S. Ganz
Item 4 of the Schedule 13D is hereby amended and supplemented as follows (which shall be in addition to the information previously included in the Schedule 13D): The Reporting Persons are making this filing to disclose the following information: In his last 13D filing, Mr. Ganz reported that as part of his conversations with five of the Company's board members, he provided the Board with the names of "two highly qualified board candidates, each of whom have built businesses worth several hundreds of millions or billions of dollars over their careers and each of whom have served on numerous public boards." Both individuals are luminaries with proven track records building extremely successful businesses that have a direct connection to the Company's business. Mr. Ganz is pleased that the Byrna Board has decided to bring one of these candidates, Matt McBrady, onto the Byrna Board and to include him in their proposed Board slate for the upcoming shareholders meeting. In Mr. Ganz's view, Mr. McBrady brings unparalleled experience in the less-lethal market, having been a director of Axon (TASER) from 2001 to 2014 and again from late 2016 through early 2026. Mr. McBrady joined the TASER Board for the first time several months before its IPO when annual revenues were in the single-digit millions of dollars and then left when he became the CIO of Blackrock's Multi-strategy hedge fund platform. Mr. McBrady rejoined the TASER Board in late 2016 as TASER was making the transition …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-09-08; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-06 | Fmr LLC | 15% | SCHEDULE 13G/A |
| 2025-11-04 | Ganz Bryan | 7.6% | SCHEDULE 13D/A |
| 2026-02-12 | Capital Research Global Investors | 6.2% | SCHEDULE 13G/A |
| 2026-04-16 | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-05-14 | Capital Research Global Investors | 0% | SCHEDULE 13G/A |
| 2026-07-10 | Millennium Management LLC | 1.4% | SCHEDULE 13G/A |
| 2026-07-27 | BlackRock, Inc. | 1.7% | SCHEDULE 13G/A |
| 2026-07-28 | Bryan Ganz | 9.9% | SCHEDULE 13D/A |
| 2026-08-07 | Fmr LLC | 7.2% | SCHEDULE 13G/A |
| 2026-08-12 | Bryan S. Ganz | 9.9% | SCHEDULE 13D/A |
| 2026-09-08 | Bryan S. Ganz | 9.6% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Byrna Technologies Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.